What Do We Really Know About Cardiovascular Disease in the HIV-infected Population?

Samir K. Gupta, MD, MS
Associate Professor of Medicine, Division of Infectious Diseases
Indiana University School of Medicine, Indianapolis, IN

CME VIDEOTop of page

Learning Objectives:Top of page

At the completion of this educational session, participants should be able to:
  • Compare the epidemiology of cardiovascular disease in those with and without HIV infection.
  • Differentiate the contributions of HIV medications vs. the infection itself on cardiovascular disease.
  • Predict which interventions may reduce the increased risk of cardiovascular disease in HIV-infected patients.

About the Presenter:Top of page

Samir Gupta is an HIV care provider at the Wishard Memorial Hospital (the county hospital for Indianapolis) and has participated in clinical research focusing on the effects of HIV and ART on renal and cardiovascular diseases. Dr. Gupta receives funding from both the NIH and industry to support these ongoing research efforts. In particular, Dr. Gupta is the Principal Investigator for one of the NIH-CVD collaborative research programs.

How To Get CMETop of page

To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.

You must be logged in to post a comment. Login | Register